February 16, 2017 09:39 AM EST

Alkermes CEO Pops stays focused on 5461 filing plans; Shkreli gets booed at Harvard

Shehla Shakoor

Managing Director

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Updated: Trump administration halts more than $750M in funds for Moderna’s bird flu vaccine

A new dawn for psychedelics? Compass could be the first to find out

The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fund

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation